• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 1990 年至 2019 年肝硬化发病率趋势:联合分析和年龄-时期-队列分析。

Trends in the incidence of cirrhosis in global from 1990 to 2019: A joinpoint and age-period-cohort analysis.

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Med Virol. 2023 Jun;95(6):e28858. doi: 10.1002/jmv.28858.

DOI:10.1002/jmv.28858
PMID:37306296
Abstract

Cirrhosis remains a major public health concern globally; the burden of cirrhosis should be further clarified worldwide and helped us to understand the current situation of cirrhosis. In the present study, we estimate DALYs and mortality rates attributable to several major cirrhosis risk factors and use joinpoint and age-period-cohort methods to determine the trends of cirrhosis incidence and deaths in the global population in the 1990-2019 period. Globally, from 1990 to 2019, the incidence of cirrhosis, deaths due to cirrhosis, and cirrhosis DALY cases increased from 1274 (10 , 95% uncertainty interval [UI]: 1027.2-1548.5) to 2051.6 (10 , 95% UI: 1661.4-2478.1), 1013 (10 , 95% UI: 948.9-1073.9) to 1472 (10 , 95% UI: 1374.6-1578.7), and 34727.7 (10 , 95% UI: 32383.0-37132.8) to 46189.4 (10 , 95% UI: 43027.1-49551.3), respectively. Hepatitis virus was the most important cirrhosis mortality risk factor. Globally, hepatitis virus infection (HBV+HCV) accounted for more than 45% of the incidence of cirrhosis cases and about 50% of cirrhosis deaths. Importantly, from 1990 to 2019, the proportion of cirrhosis incidence due to HBV decreased from 24.3% to 19.8%, whereas that due to alcohol use increased from 18.7% to 21.3%. Additionally, the proportion of NAFLD-induced cirrhosis incidence increased from 5.5% to 6.6% over the same period. Our findings on the global disease burden of cirrhosis provide a valuable resource for developing targeted prevention strategies.

摘要

肝硬化仍然是全球主要的公共卫生关注点;需要在全球范围内进一步明确肝硬化的负担,以帮助我们了解当前肝硬化的情况。在本研究中,我们估计了几个主要肝硬化风险因素导致的残疾调整生命年(DALY)和死亡率,并使用 joinpoint 和年龄-时期-队列方法来确定全球人群在 1990-2019 年期间肝硬化发病率和死亡率的趋势。

全球范围内,1990 年至 2019 年,肝硬化发病率、肝硬化死亡人数和肝硬化 DALY 病例数分别从 1274(10 ,95%不确定区间 [UI]:1027.2-1548.5)上升至 2051.6(10 ,95% UI:1661.4-2478.1)、1013(10 ,95% UI:948.9-1073.9)上升至 1472(10 ,95% UI:1374.6-1578.7)和 34727.7(10 ,95% UI:32383.0-37132.8)上升至 46189.4(10 ,95% UI:43027.1-49551.3)。肝炎病毒是最重要的肝硬化死亡风险因素。全球范围内,肝炎病毒感染(HBV+HCV)导致的肝硬化病例占比超过 45%,肝硬化死亡人数占比约 50%。重要的是,1990 年至 2019 年,HBV 导致的肝硬化发病率比例从 24.3%下降至 19.8%,而酒精使用导致的肝硬化发病率比例从 18.7%上升至 21.3%。此外,NAFLD 导致的肝硬化发病率比例同期从 5.5%上升至 6.6%。我们对全球肝硬化疾病负担的研究结果为制定有针对性的预防策略提供了有价值的资源。

相似文献

1
Trends in the incidence of cirrhosis in global from 1990 to 2019: A joinpoint and age-period-cohort analysis.全球 1990 年至 2019 年肝硬化发病率趋势:联合分析和年龄-时期-队列分析。
J Med Virol. 2023 Jun;95(6):e28858. doi: 10.1002/jmv.28858.
2
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.欧洲的乙型肝炎和丙型肝炎:来自 2019 年全球疾病负担研究的最新更新。
Lancet Public Health. 2023 Sep;8(9):e701-e716. doi: 10.1016/S2468-2667(23)00149-4.
3
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
4
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019.全球 1990 年至 2019 年因特定病因导致的肝硬化和其他慢性肝病负担。
BMC Public Health. 2024 Feb 3;24(1):363. doi: 10.1186/s12889-024-17948-6.
5
Worldwide burden of liver cancer across childhood and adolescence, 2000-2021: a systematic analysis of the Global Burden of Disease Study 2021.2000 - 2021年全球儿童和青少年肝癌负担:对《2021年全球疾病负担研究》的系统分析
EClinicalMedicine. 2024 Jul 26;75:102765. doi: 10.1016/j.eclinm.2024.102765. eCollection 2024 Sep.
6
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.非酒精性脂肪性肝病在亚洲、中东和北非地区的负担:来自 2009-2019 年全球疾病负担的数据。
J Hepatol. 2021 Oct;75(4):795-809. doi: 10.1016/j.jhep.2021.05.022. Epub 2021 May 31.
7
Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.全球各国、各地区及全球范围内肝硬化患者中乙型肝炎病毒和丙型肝炎病毒的流行情况:系统评价。
Lancet Gastroenterol Hepatol. 2022 Aug;7(8):724-735. doi: 10.1016/S2468-1253(22)00050-4. Epub 2022 May 14.
8
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study.1990-2013 年 20-64 岁成年人中的中风发病率、死亡率和伤残调整生命年:来自 2013 年全球疾病负担研究的数据。
Neuroepidemiology. 2015;45(3):190-202. doi: 10.1159/000441098. Epub 2015 Oct 28.
9
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.估算因注射吸毒作为 HIV、丙型肝炎和乙型肝炎的风险因素而导致的疾病负担:来自 2013 年全球疾病负担研究的结果。
Lancet Infect Dis. 2016 Dec;16(12):1385-1398. doi: 10.1016/S1473-3099(16)30325-5. Epub 2016 Sep 21.
10
Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.儿童和青少年(0-19 岁)中的卒中发生率、死亡率和伤残调整生命年:来自全球和区域卒中负担 2013 的数据。
Neuroepidemiology. 2015;45(3):177-89. doi: 10.1159/000441087. Epub 2015 Oct 28.

引用本文的文献

1
Contrasting tracheal, bronchus, and lung cancer burdens and care quality: a comparative analysis of China and global trends.对比气管、支气管和肺癌负担及医疗质量:中国与全球趋势的比较分析
BMC Cancer. 2025 Aug 11;25(1):1298. doi: 10.1186/s12885-025-14645-4.
2
Liver cirrhosis in 2021: Global Burden of Disease study.2021年肝硬化:全球疾病负担研究
PLoS One. 2025 Jul 18;20(7):e0328493. doi: 10.1371/journal.pone.0328493. eCollection 2025.
3
Inequalities and age-period-cohort effects of global and regional burden for interstitial lung disease and pulmonary sarcoidosis: based on Global Burden of Disease study 2021.
间质性肺疾病和结节病的全球及区域负担的不平等与年龄-时期-队列效应:基于《2021年全球疾病负担研究》
Front Med (Lausanne). 2025 May 26;12:1471402. doi: 10.3389/fmed.2025.1471402. eCollection 2025.
4
Secular trend in disease burden of atrial fibrillation/flutter in China from 1992 to 2021 and its projection in 25 years.1992年至2021年中国房颤/心房扑动疾病负担的长期趋势及其未来25年预测
BMC Public Health. 2025 Jun 3;25(1):2064. doi: 10.1186/s12889-025-23322-x.
5
Trends in Syphilis Incidence and Its Association With the Number of Sex Industry-Related Businesses in Japan: An Ecological Study Using Joinpoint Analysis.日本梅毒发病率趋势及其与性产业相关企业数量的关联:一项使用Joinpoint分析的生态学研究
Cureus. 2025 May 1;17(5):e83294. doi: 10.7759/cureus.83294. eCollection 2025 May.
6
Development and validation of a scoring system to predict MASLD patients with significant hepatic fibrosis.预测合并显著肝纤维化的代谢相关脂肪性肝病(MASLD)患者的评分系统的开发与验证
Sci Rep. 2025 Mar 20;15(1):9639. doi: 10.1038/s41598-025-91013-z.
7
Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021.1990年至2035年全球青少年和青年人群中乙型肝炎相关肝硬化的时间趋势及预测:基于2021年全球疾病负担研究的分析
Front Public Health. 2025 Jan 8;12:1494388. doi: 10.3389/fpubh.2024.1494388. eCollection 2024.
8
Artificial intelligence-based evaluation of prognosis in cirrhosis.基于人工智能的肝硬化预后评估。
J Transl Med. 2024 Oct 14;22(1):933. doi: 10.1186/s12967-024-05726-2.
9
Global burden of adult non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been steadily increasing over the past decades and is expected to persist in the future.在过去几十年中,成人非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球负担一直在稳步增加,预计未来仍将持续。
Transl Gastroenterol Hepatol. 2024 Jun 24;9:33. doi: 10.21037/tgh-23-118. eCollection 2024.
10
The intervention of curcumin on rodent models of hepatic fibrosis: A systematic review and meta-analysis.姜黄素对肝纤维化啮齿类动物模型的干预作用:系统评价和荟萃分析。
PLoS One. 2024 May 23;19(5):e0304176. doi: 10.1371/journal.pone.0304176. eCollection 2024.